InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

BIOCRYST PHARMACEUTICALS INC

BCRX Clue Score70
United States Fiscal year ends December CIK 0000882796 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Amy E McKee
18 May 2026
Director
Sell
11,180
$8.97
$100.28K
Alane P Barnes
13 May 2026
Chief Legal Officer
Sold after exercise
62,500
$9.54
$596.25K
Theresa Heggie
20 Mar 2026
Director
Sold after exercise
49,933
$10.11
$504.82K
Alane P Barnes
16 Mar 2026
Chief Legal Officer
Sold after exercise
150,000
$9.15
$1.37M
Jon P Stonehouse
2 Mar 2026
Director
Exercised, kept
305,995
$3.22
$985.30K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
50,000
$5.51
$275.50K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
10,091
$5.04
$50.86K
Charles K Gayer
22 Dec 2025
President and CCO
Exercised, kept
14,142
$3.22
$45.54K
Alane P Barnes
22 Dec 2025
Chief Legal Officer
Sold on a plan
21,773
$7.65
$166.56K
Alane P Barnes
15 Dec 2025
Chief Legal Officer
Sold on a plan
21,210
$7.65
$162.26K
Alane P Barnes
3 Dec 2025
Chief Legal Officer
Sold on a plan
19,770
$7.65
$151.24K
Alane P Barnes
2 Dec 2025
Chief Legal Officer
Sold on a plan
50,906
$7.21
$367.22K
Alane P Barnes
1 Dec 2025
Chief Legal Officer
Sold after exercise
91,004
$7.10
$646.51K
Machelle Sanders
13 Nov 2025
Director
Sold on a plan
9,600
$7.14
$68.54K

What was left out

Form 4 filings counted 45
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 4
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,302,758
History held since 3 Nov 2006